July 6, 2021
Movano Conducts IRB-Approved Clinical Study with Prototype Blood Pressure Device
Read More 9
June 8, 2021
Movano Inc. Set to Join Russell Microcap Index
Read More 9
May 13, 2021
Movano Inc. Provides Business Update and Reports First Quarter 2021 Financial Results
Read More 9
April 21, 2021
Movano Inc. to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
Read More 9
March 25, 2021
Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO
Read More 9
March 25, 2021
Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
Read More 9
March 23, 2021
Movano Inc. Prices $42.5 Million Public Offering of Common Stock
Read More 9
September 24, 2020
GLOBALFOUNDRIES and Movano Inc. Partner to Advance Needle-Free Continuous Glucose Monitoring Technology
Read More 9
August 29, 2020
Movano Inc. Closes Bridge Financing Round at $12.5M
Read More 9
July 14, 2020
Movano Inc. Exits Stealth Mode and Secures $10M in Additional Funding to Transform Glucose Monitoring with Non-Invasive Technology
Read More 9
